Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data
- PMID: 33257958
- PMCID: PMC7850039
- DOI: 10.1093/eurheartj/ehaa885
Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data
Erratum in
-
Corrigendum to: Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.Eur Heart J. 2021 Apr 7;42(14):1443. doi: 10.1093/eurheartj/ehab073. Eur Heart J. 2021. PMID: 33585886 Free PMC article. No abstract available.
Abstract
Aims: The prognostic importance of cardiac procedural myocardial injury and myocardial infarction (MI) in chronic coronary syndrome (CCS) patients undergoing elective percutaneous coronary intervention (PCI) is still debated.
Methods and results: We analysed individual data of 9081 patients undergoing elective PCI with normal pre-PCI baseline cardiac troponin (cTn) levels. Multivariate models evaluated the association between post-PCI elevations in cTn and 1-year mortality, while an interval analysis evaluated the impact of the size of the myocardial injury on mortality. Our analysis was performed in the overall population and also according to the type of cTn used [52.0% had high-sensitivity cTn (hs-cTn)]. Procedural myocardial injury, as defined by the Fourth Universal Definition of MI (UDMI) [post-PCI cTn elevation ≥1 × 99th percentile upper reference limit (URL)], occurred in 52.8% of patients and was not associated with 1-year mortality [adj odds ratio (OR), 1.35, 95% confidence interval (CI) (0.84-1.77), P = 0.21]. The association between post-PCI cTn elevation and 1-year mortality was significant starting ≥3 × 99th percentile URL. Major myocardial injury defined by post-PCI ≥5 × 99th percentile URL occurred in 18.2% of patients and was associated with a two-fold increase in the adjusted odds of 1-year mortality [2.29, 95% CI (1.32-3.97), P = 0.004]. In the subset of patients for whom periprocedural evidence of ischaemia was collected (n = 2316), Type 4a MI defined by the Fourth UDMI occurred in 12.7% of patients and was strongly associated with 1-year mortality [adj OR 3.21, 95% CI (1.42-7.27), P = 0.005]. We also present our results according to the type of troponin used (hs-cTn or conventional troponin).
Conclusion: Our analysis has demonstrated that in CCS patients with normal baseline cTn levels, the post-PCI cTn elevation of ≥5 × 99th percentile URL used to define Type 4a MI is associated with 1-year mortality and could be used to detect 'major' procedural myocardial injury in the absence of procedural complications or evidence of new myocardial ischaemia.
Keywords: Elective PCI; Myocardial infarction; Myocardial injury; Procedural complication; Procedural myocardial infarction; Procedural myocardial injury.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
Figures





Comment in
-
Cardiac troponin elevation after elective PCI: adding infarct to major injury.Eur Heart J. 2021 Jan 21;42(4):335-338. doi: 10.1093/eurheartj/ehaa983. Eur Heart J. 2021. PMID: 33410468 No abstract available.
-
Appropriate criteria for the definition of Type 4a MI.Eur Heart J. 2022 Mar 3;43(10):1013-1014. doi: 10.1093/eurheartj/ehab808. Eur Heart J. 2022. PMID: 34849693 No abstract available.
-
Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?Eur Heart J. 2022 Mar 7;43(10):1012. doi: 10.1093/eurheartj/ehab805. Eur Heart J. 2022. PMID: 34849705 Free PMC article. No abstract available.
Similar articles
-
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).Eur Heart J. 2021 Jul 15;42(27):2630-2642. doi: 10.1093/eurheartj/ehab271. Eur Heart J. 2021. PMID: 34059914 Free PMC article.
-
The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC).Biomarkers. 2022 Jul;27(5):407-417. doi: 10.1080/1354750X.2022.2055792. Epub 2022 May 26. Biomarkers. 2022. PMID: 35603440 Free PMC article. Review.
-
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.Circulation. 2025 Mar 18;151(11):760-772. doi: 10.1161/CIRCULATIONAHA.124.070729. Epub 2025 Feb 19. Circulation. 2025. PMID: 39968630 Free PMC article.
-
Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.JACC Cardiovasc Interv. 2021 Aug 9;14(15):1623-1634. doi: 10.1016/j.jcin.2021.05.006. JACC Cardiovasc Interv. 2021. PMID: 34353593
-
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.J Am Coll Cardiol. 2013 Jul 16;62(3):242-251. doi: 10.1016/j.jacc.2013.04.043. Epub 2013 May 15. J Am Coll Cardiol. 2013. PMID: 23684676 Review.
Cited by
-
Real-World Data on Potent P2Y12 Inhibition in Patients with Suspected Chronic Coronary Syndrome, Referred for Coronary Angiography.Cardiology. 2022;147(5-6):486-496. doi: 10.1159/000527459. Epub 2022 Oct 10. Cardiology. 2022. PMID: 36215960 Free PMC article.
-
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies.Diagnostics (Basel). 2022 Nov 1;12(11):2659. doi: 10.3390/diagnostics12112659. Diagnostics (Basel). 2022. PMID: 36359502 Free PMC article. Review.
-
Towards a common pathway for the treatment of left main disease: contemporary evidence and future directions: Left main disease treatment.AsiaIntervention. 2021 Dec;7(2):85-95. doi: 10.4244/AIJ-D-21-00022. AsiaIntervention. 2021. PMID: 34913011 Free PMC article. Review.
-
Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.Circulation. 2021 Feb 23;143(8):790-804. doi: 10.1161/CIRCULATIONAHA.120.047987. Epub 2020 Dec 3. Circulation. 2021. PMID: 33267610 Free PMC article. Clinical Trial.
-
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).Eur Heart J. 2021 Jul 15;42(27):2630-2642. doi: 10.1093/eurheartj/ehab271. Eur Heart J. 2021. PMID: 34059914 Free PMC article.
References
-
- Giacoppo D, Colleran R, Cassese S, Frangieh AH, Wiebe J, Joner M, Schunkert H, Kastrati A, Byrne RA. Percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: a systematic review and meta-analysis. JAMA Cardiol 2017;2:1079–1088. - PMC - PubMed
-
- Valgimigli M, Frigoli E, Leonardi S, Vranckx P, Rothenbühler M, Tebaldi M, Varbella F, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andó G, Ferrario M, Limbruno U, Garbo R, Sganzerla P, Russo F, Nazzaro M, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Ferrante G, Santarelli A, Sardella G, de Cesare N, Tosi P, van 't Hof A, Omerovic E, Brugaletta S, Windecker S, Heg D, Jüni P, Campo G, Uguccioni L, Tamburino C, Presbitero P, Zavalloni-Parenti D, Ferrari F, Ceravolo R, Tarantino F, Pasquetto G, Casu G, Mameli S, Stochino ML, Mazzarotto P, Cremonesi A, Saia F, Saccone G, Abate F, Picchi A, Violini R, Colangelo S, Boccuzzi G, Guiducci V, Vigna C, Zingarelli A, Gagnor A, Zaro T, Tresoldi S, Vandoni P, Contarini M, Liso A, Dellavalle A, Curello S, Mangiacapra F, Evola R, Palmieri C, Falcone C, Liistro F, Creaco M, Colombo A, Chieffo A, Perkan A, De Servi S, Fischetti D, Rigattieri S, Sciahbasi A, Pucci E, Romagnoli E, Moretti C, Moretti L, De Caterina R, Caputo M, Zimmarino M, Bramucci E, Di Lorenzo E, Turturo M, Bonmassari R, Penzo C, Loi B, Mauro C, Petronio AS, Gabrielli G, Micari A, Belloni F, Amico F, Comeglio M, Fresco C, Klinieken I, Van Mieghem N, Diletti R, Regar E, Sabaté M, Gómez Hospital JA, Díaz Fernández JF, Mainar V, de la Torre Hernandez JM. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial. Lancet 2018;392:835–848. - PubMed
-
- Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, Kandzari DE, Morice M-C, Lembo N, Brown WM, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, Boven A. V, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Pagé P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein P. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 2016;375:2223–2235. - PubMed
-
- Ndrepepa G, Colleran R, Braun S, Cassese S, Hieber J, Fusaro M, Kufner S, Ott I, Byrne RA, Husser O, Hengstenberg C, Laugwitz K-L, Schunkert H, Kastrati A. High-sensitivity troponin t and mortality after elective percutaneous coronary intervention. J Am Coll Cardiol 2016;68:2259–2268. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous